Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer

Erythropoiesis-stimulating agents (ESAs) increase red blood cell (RBC) production in bone marrow by activating the erythropoietin receptor (EpoR) on erythrocytic-progenitor cells. Erythropoiesis-stimulating agents are approved in the United States and Europe for treating anaemia in cancer patients r...

Descripción completa

Detalles Bibliográficos
Autores principales: Aapro, M, Jelkmann, W, Constantinescu, S N, Leyland-Jones, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314780/
https://www.ncbi.nlm.nih.gov/pubmed/22395661
http://dx.doi.org/10.1038/bjc.2012.42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314780/
https://www.ncbi.nlm.nih.gov/pubmed/22395661
http://dx.doi.org/10.1038/bjc.2012.42

Ejemplares similares